Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Andrew Haydon"'
Autor:
Joshua D. Cohen, Lisa Dobbyn, Desmond Yip, Jeanne Tie, Maria Popoli, Peter Gibbs, Bert Vogelstein, Yuxuan Wang, Cristian Tomasetti, Iain Skinner, Janine Ptak, Kenneth W. Kinzler, Hui-Li Wong, Christos S. Karapetis, Natalie Silliman, Suzanne Kosmider, Nickolas Papadopoulos, Matthew Burge, Mary J. Schaeffer, Timothy J. Price, Rachel Wong, Lu Li, Andrew Haydon, Belinda Lee, Margaret Lee, Niall C. Tebbutt, Serigne Lo, Michael Christie
Publikováno v:
Int J Cancer
Studies in multiple solid tumor types have demonstrated the prognostic significance of ctDNA analysis after curative intent surgery. A combined analysis of data across completed studies could further our understanding of circulating tumor DNA (ctDNA)
Autor:
John Zalcberg, John J McNeil, Jessica E. Lockery, Anne Murray, Suzanne G Orchard, Galina Polehkina, Rory Wolfe, Mark Nelson, Robyn L. Woods, Peter Gibbs, Brenda Kirpach, Christopher M. Reid, Andrew Haydon
Publikováno v:
International Journal of Epidemiology. 50
Background The ASPirin in Reducing Events in the Elderly (ASPREE) study randomised healthy older individuals to 100mg aspirin or placebo, with clinical outcomes and disability-free survival endpoints. Detailed baseline data provides a rare opportunit
Autor:
Stephanie A. Smith-Warner, Andrew Haydon, John L. Hopper, Graham G. Giles, Harindra Jayasekara, Roger L. Milne, Robin Room, Robert J. MacInnis, Allison M. Hodge, Dallas R. English
Publikováno v:
International journal of cancerREFERENCES.
Alcohol consumption is a known cause of cancer, but its role in the etiology of second primary (metachronous) cancer is uncertain. Associations between alcohol intake up until study enrollment (prediagnosis) and risk of metachronous cancer were estim
Autor:
Tony Blakely, Kathryn Whitfield, Nina Afshar, Victoria White, Luc te Marvelde, Roger L. Milne, S. Ghazaleh Dashti, Rebecca J Bergin, Andrew Haydon, Jon Emery, Robert J. Thomas, Dallas R. English, Graham G. Giles
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 30(10)
Background: Socio-economic inequalities in colon cancer survival exist in high-income countries, but the reasons are unclear. We assessed the mediating effects of stage at diagnosis, comorbidities, and treatment (surgery and intravenous chemotherapy)
Autor:
Michelle Frances Morris, Andrea Harkin, Martin R. Stockler, Eva Segelov, Timothy Iveson, Christine Aiken, Niall C. Tebbutt, Prunella Blinman, David Boadle, Andrew Haydon, Andrew J. Martin, David Goldstein, Michael Jefford
Publikováno v:
JNCI Cancer Spectrum
Background SCOT was an international, randomized phase 3 trial of 3 months vs 6 months of adjuvant chemotherapy with oxaliplatin and a fluoropyrimidine in patients with colorectal cancer. We sought patients’ preferences for 3 months vs 6 months of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ec577da178882f0af2cfb5e452f04c
Autor:
Cristian Tomasetti, Dusan Kotasek, Bert Vogelstein, Craig Underhill, Suzanne Kosmider, Julian Choi, Peter Gibbs, Adrian Fox, Wei Hong, Yuxuan Wang, Hui-Li Wong, Jeanne Tie, Christos S Karapetis, Niall C. Tebbutt, Joy Schaeffer, Benjamin N. J. Thomson, Lu Li, Andrew Haydon, Matthew Burge, Joshua D. Cohen, Jenny Shannon, Janine Ptak, Michael Christie, Kenneth W. Kinzler, Kathryn M. Field, Nicholas Papadopoulos, Rachel Wong
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 18, Iss 5, p e1003620 (2021)
PLoS Medicine, Vol 18, Iss 5, p e1003620 (2021)
Background In patients with resectable colorectal liver metastases (CRLM), the role of pre- and postoperative systemic therapy continues to be debated. Previous studies have shown that circulating tumor DNA (ctDNA) analysis, as a marker of minimal re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffca5f1804285e3c3daa386a9dc7debe
Autor:
Amanda C. Stanley, Darryn Bampton, Andrew Clouson, Nick Pavlakis, Charlotte Lemech, Keith Dredge, Matthew Burge, Nigel J. Waterhouse, David Goldstein, Andrew Haydon, Lucie Leveque-ElMouttie, Grace Chojnowski, Michael P. Brown, Edward Hammond
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPixatimod is a novel immunomodulatory agent which stimulates dendritic cells (DC) via Toll-Like Receptor 9 (TLR9) pathway to activate natural killer (NK) cells.1 It also enhances T cell infiltration into tumors when combined with PD1 inhibi
Autor:
Natallie Silliman, Suzanne Kosmider, Bert Volgestein, Desmond Yip, Hany Elsaleh, Madhu Sudan Singh, David Goldstein, Yuxuan Wang, Matthew Burge, Carolyn Bampton, Iain Skinner, Timothy J. Price, Christos S. Karapetis, Matthew Croxford, Jeanne Tie, Cristian Tomasetti, Ian T. Jones, Lu Li, Andrew Haydon, Rachel Wong, Michael Christie, David Rangiah, Joshua D. Cohen, Mary J Schaefer, Margaret Lee, Nickolas Papadopoulos, Peter Gibbs, Ben Tran, Kenneth W. Kinzler, Koen Simons, Jeanne Ptak, Isaac Kinde, Ian Faragher, Lisa Dobbyn
Publikováno v:
Flinders University PURE
ObjectiveFor patients with locally advanced rectal cancer (LARC), adjuvant chemotherapy selection following surgery remains a major clinical dilemma. Here, we investigated the ability of circulating tumour DNA (ctDNA) to improve risk stratification i
Autor:
Harindra Jayasekara, Elizabeth A. Williamson, Graham G. Giles, Brigid M. Lynch, Mark A. Jenkins, Robin Room, Roger L. Milne, Melissa C. Southey, Allison M. Hodge, Andrew Haydon, Mark Clendenning, Robert J. MacInnis, Daniel D. Buchanan, Dallas R. English, Christophe Rosty, John L. Hopper
Publikováno v:
International Journal of Cancer. 142:238-250
The influence of lifestyle factors on survival following a diagnosis of colorectal cancer (CRC) is not well established. We examined associations between lifestyle factors measured before diagnosis and CRC survival. The Melbourne Collaborative Cohort
Autor:
Peter Carne, Lewis Au, Simon Wilkins, Andrew Haydon, Adrian L. Polglase, Stephen Bell, Karen Oliva, Roger Wale, Yoland Antill, P. Ranchod, Chip Farmer, Jeremy Shapiro, Matthew Grant, Martin Chin, Stewart Skinner, Paul J. McMurrick, Paul Simpson, Eva Segelov
Publikováno v:
International journal of surgery (London, England). 51
Background/Objectives Adjuvant chemotherapy for Stage II colon cancer offers a small (2-3%) overall survival benefit and is not universally recommended. Mismatch repair deficiency (dMMR) confers an improved prognosis identifying patients unlikely to